A CD40 agonist antibody was combined with gemcitabine for treating 22 advanced PDA patients [61]; this achieved promising results and opens the door to a couple more clinical trials with CD40 agonist and chemotherapy, with results yet to be published. This evidence concerns the gene CD40 and Patent ductus arteriosus.